In a research report issued this morning, H.C.
Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced two posters presented yesterday at the annual meeting of the American College of Cardiology (ACC). This research adds to …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that target patient enrollment has been reached in its REDUCE-IT cardiovascular outcomes trial of Vascepa (icosapent ethyl). Amarin …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced settlement terms have been reached among the parties to resolve the Amarin First Amendment litigation (Amarin Pharma, Inc. …
MannKind Corporation Piper Jaffray analyst Joshua Schimmer weighed in on shares of MannKind Corporation (NASDAQ:MNKD) after the company’s founder passed away today at the age …
Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that parties to the Amarin First Amendment litigation have jointly requested a continued stay in court proceedings. Following the …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has appointed Craig B. Granowitz, M.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that it and its wholly owned subsidiary, Corsicanto Limited, a private limited company incorporated under the laws of …
